TGFBR1 and colorectal carcinoma: Here, using a more robust technique for ASE determination, studying Ashkenazi Jewish and Caucasian populations, and using different sources of non-tumoral genetic material, we identified no differences in the degree or frequency of ASE of TGFBR1 between CRC patients and controls, discarding its role in CRC predisposition.